Glucotrack, Inc. (GCTK) Form S-1/A — Oct 13, 2026
Glucotrack filed an S-1/A registering the resale of up to 43,223,705 shares by selling stockholders, roughly 1,825% of its 2,368,237 shares outstanding. The shares stem from bridge notes, an ELOC agreement with White Lion Capital, PIPE financings, and convertible notes, and the company receives no proceeds from the resales other than up to $50 million it may draw under the ELOC line.
Key figures
- Shares Offered
- 43223705
- Shares Outstanding
- 2,368,237 (as of Oct 5, 2026); 45,591,942 pro forma
- Cash
- $3,900,000 (March 31, 2026)
- Eloc facility
- $50,000,000 over three years
- Last sale price
- $1.13 (Oct 6, 2026)
- Interim pipe gross
- $2,000,000
- Accumulated deficit
- $156,200,000 (March 31, 2026)
- Notes interest rate
- 8% per annum
- Reverse split ratio
- 1:15
- Bridge financing gross
- $7,950,000
- Dilution vs outstanding
- 1,825%
- Original issue discount
- 22%
- Lokahi holders ownership
- 90.0% fully diluted post-merger
- September notes principal
- $11,596,172.68
- September pipe gross proceeds
- $4,500,000
- Registered direct gross proceeds
- $3,100,000
AI analysis
Red flags8 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.